Cancer News and Research

Latest Cancer News and Research

Physical activity, healthy diets open gateway to preventive lifestyle

"A physical active lifestyle opens the gateway to a preventive lifestyle including healthy diets" - this was the main message from a scientific presentation of Prof. Wolgang Schlicht, Institute of Sport and Health Sciences, Stuttgart University, held during the last meeting of the EU supported Food Cluster Initiative in Ghent, Belgium.

17 Dec 2010

Amira identifies novel pre-clinical candidate for autotaxin lysophosphatidic acid related program

Amira Pharmaceuticals, Inc. announced today that it has successfully identified a novel pre-clinical candidate for its newest lysophosphatidic acid (LPA)-related program, autotaxin. Autotaxin is an enzyme upstream from LPA receptors and has been implicated in a number of diseases including rheumatoid arthritis, glioblastoma, lung, breast, ovarian and thyroid cancers.

17 Dec 2010

Elsevier Foundation's new library grants focus on telemedicine, HIV/AIDS videos and Egyptian cancer database

The Elsevier Foundation has announced the 2010 recipients of grants under its Innovative Libraries in Developing Countries program, committing over $300,000 to support the work of libraries in developing countries. The 2010 grant recipients were selected from 260 proposals worldwide for their innovation and potential for impact in the developing world. The Innovative Libraries program supports capacity-building projects in the science, technology and medicine library training, education, infrastructure, digitization and the preservation of information.

17 Dec 2010

Diagenic, Pfizer enter collaboration to identify biomarkers in early stages of Alzheimer's disease

DiaGenic ASA and Pfizer Inc today signed an agreement for explorative R&D collaboration to identify biomarkers in early stages of Alzheimer's disease (AD) using DiaGenic's patented gene expression technology and its blood samples from ongoing clinical studies.

17 Dec 2010

Health inequalities still exist between England's richest and poorest

Significant health inequalities still exist between the country's richest and poorest according to the latest findings from the biggest annual survey of health in England, The Health Survey for England. The survey, conducted by the National Centre for Social Research and UCL and funded by The NHS Information Centre, shows that people in the lowest income households continue to experience much worse outcomes across key health measures than people in the highest income households.

17 Dec 2010

Celator granted U.S. Patent covering CombiPlex technology platform

Celator Pharmaceuticals today announced the United States Patent and Trademark Office issued U.S Patent No. 7,850,990. This patent adds to the intellectual property surrounding Celator's innovative technology platforms and products.

17 Dec 2010

Researchers contribute important expertise to new landmark study of medulloblastoma

Pediatric cancer researchers at The Children's Hospital of Philadelphia contributed important expertise to a new landmark study of medulloblastoma, a type of brain tumor typically found in children. The large multicenter study defines the genetic landscape of this cancer, and holds intriguing clues to gene changes on signaling pathways that may become fruitful targets for future therapies.

17 Dec 2010

Researchers discover new way to prevent spread of cancer

Scientists now know that some cancer cells spread, or metastasize, throughout the body the old-fashioned way -- by using their feet. But researchers at Duke Cancer Institute have discovered a way to short-circuit their travels by preventing the development of these feet, called invadopodia. This discovery is even more important because preventing the development of these "feet" also eliminates the action of proteins present in the feet that burn through intact tissue and let cancer cells enter new cells.

17 Dec 2010

Cancer Treatment Centers of America deploys Intel's personal health system solution

Cancer Treatment Centers of America (CTCA) is deploying the Intel® Health Guide - a next-generation personal health system solution that allows physicians and clinicians to proactively monitor their patients' care at home - as part of its commitment to provide patients with the information and resources they need to make educated decisions about their cancer care.

17 Dec 2010

FDA's decision on Avastin will take away choice for many patients, says Breastcancer.org

Dr. Marisa Weiss, president and founder of Breastcancer.org and a breast oncologist in the Philadelphia area submitted a letter to the U.S. Food and Drug Administration prior to the Oncology Drug Advisory Committee (ODAC) meeting to review data for Avastin's use in metastatic HER2-negative breast cancer. In light of today's news that the FDA has recommended removing Avastin's approval to treat breast cancer, Breastcancer.org is making public Dr. Weiss' ODAC letter in its entirety.

17 Dec 2010

'Histone code' needs to be used with caution

The function of histones -- the proteins that enable yards of DNA to be crammed into a single cell -- depends on a number of chemical tags adorning their exterior. This sophisticated chemical syntax for packaging DNA into tight little coils or unraveling it again -- called the "histone code" -- is the latest frontier for researchers bent on understanding how genetics encodes life.

17 Dec 2010

AHA recognizes UC Irvine Medical Center's commitment to high-quality cardiac care

The American Heart Association has recognized UC Irvine Healthcare's commitment to the highest standards of care for heart failure patients.

17 Dec 2010

Whitehead Institute Founding Member named recipient of 2011 Warren Triennial Prize of MGH

Whitehead Institute Founding Member Rudolf Jaenisch has been named a recipient of the 2011 Warren Triennial Prize of Massachusetts General Hospital.

17 Dec 2010

Genentech confirms EMA, FDA updates on Avastin for metastatic breast cancer

Genentech, a member of the Roche Group, confirmed that following the reviews of Avastin® (bevacizumab) in metastatic breast cancer by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA), the following regulatory announcements were made by the individual health authorities:

17 Dec 2010

Electronic cigarettes much safer than real cigarettes, says BUSPH researcher

In a new report that bucks the concerns raised by the Food and Drug Administration, a Boston University School of Public Health (BUSPH) (sph.bu.edu) researcher concludes that electronic cigarettes are much safer than real cigarettes and show promise in the fight against tobacco-related diseases and death.

17 Dec 2010

Children's Hospitals and Clinics of Minnesota praises fix of orphan drug discount under 340B program

Families who were facing the prospect of huge increases in the cost of life-saving drugs for their children can breath easier thanks to a new law that will preserve discounts on specialized, so-called "orphan drugs."

17 Dec 2010

Merck, sanofi-aventis enter global cancer research and development agreement

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that Merck, has signed a worldwide research and development agreement with sanofi-aventis U.S. Inc., under which Merck Serono and sanofi-aventis U.S. Inc. will collaboratively investigate novel experimental combinations of agents that could block specific pathways in cancer cells. This collaboration could deliver novel targeted oncology treatments with high therapeutic potential.

17 Dec 2010

Pediatric cancer researchers study medulloblastoma for new treatment

Pediatric cancer researchers at The Children's Hospital of Philadelphia contributed important expertise to a new landmark study of medulloblastoma, a type of brain tumor typically found in children.

17 Dec 2010

Alnylam Pharmaceuticals progress in delivery and translation of RNAi therapeutics

Alnylam Pharmaceuticals, a leading RNAi therapeutics company, presented new data at the 2010 International Chemical Congress of Pacific Basin Societies, being held in Honolulu, Hawaii, December 15-20.

17 Dec 2010

First comprehensive guide to hospital emergency preparedness exercise development

With the publication of the nation's first comprehensive, federally funded guide to hospital emergency preparedness exercise development, Dr. Nathaniel Hupert at Weill Cornell Medical College and his collaborators have provided a new toolset for strengthening hospitals' ability to protect communities nationwide against public health disasters, such as creating care centers during an influenza pandemic or treating casualties in the wake of a bioterrorism attack.

17 Dec 2010

Cancer News and Research

Latest Cancer News and Research

Physical activity, healthy diets open gateway to preventive lifestyle

Amira identifies novel pre-clinical candidate for autotaxin lysophosphatidic acid related program

Elsevier Foundation's new library grants focus on telemedicine, HIV/AIDS videos and Egyptian cancer database

Diagenic, Pfizer enter collaboration to identify biomarkers in early stages of Alzheimer's disease

Health inequalities still exist between England's richest and poorest

Celator granted U.S. Patent covering CombiPlex technology platform

Researchers contribute important expertise to new landmark study of medulloblastoma

Researchers discover new way to prevent spread of cancer

Cancer Treatment Centers of America deploys Intel's personal health system solution

FDA's decision on Avastin will take away choice for many patients, says Breastcancer.org

'Histone code' needs to be used with caution

AHA recognizes UC Irvine Medical Center's commitment to high-quality cardiac care

Whitehead Institute Founding Member named recipient of 2011 Warren Triennial Prize of MGH

Genentech confirms EMA, FDA updates on Avastin for metastatic breast cancer

Electronic cigarettes much safer than real cigarettes, says BUSPH researcher

Children's Hospitals and Clinics of Minnesota praises fix of orphan drug discount under 340B program

Merck, sanofi-aventis enter global cancer research and development agreement

Pediatric cancer researchers study medulloblastoma for new treatment

Alnylam Pharmaceuticals progress in delivery and translation of RNAi therapeutics

First comprehensive guide to hospital emergency preparedness exercise development

Understanding the DNA Damage Response in Innate Immunity eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in